{"id":"W3204859321","doi":"10.1186/s13063-021-05491-3","title":"Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial","year":2021,"lang":"en","type":"article","venue":"Trials","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Engineers Without Borders Canada","funders":"Unitaid","keywords":"Medicine; Randomized controlled trial; Regimen; Interim analysis; Tuberculosis; Randomization; Intensive care medicine; Adverse effect; Clinical trial; Rifapentine; Moxifloxacin; Protocol (science); Internal medicine; Mycobacterium tuberculosis; Alternative medicine; Antibiotics; Latent tuberculosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.0597376,0.0006139731,0.008801994,0.000263183,0.0003865134,0.0001184559,0.0002692224,0.0003644945,0.0002075276],"category_scores_gemma":[0.1749515,0.00039658,0.002312696,0.0002995437,0.0001668351,0.0001903254,0.00009408525,0.000379583,0.00001072216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002130842,"about_ca_system_score_gemma":0.001305694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004509964,"about_ca_topic_score_gemma":0.0002916873,"domain_scores_codex":[0.9784457,0.01382841,0.004383948,0.001293899,0.0009287208,0.001119341],"domain_scores_gemma":[0.9585052,0.03700049,0.001340218,0.0009550659,0.001630532,0.0005685524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9631233,0.005186723,0.0000196241,0.0002698308,0.003498805,0.000009452532,0.0006129984,0.00008029868,0.02090448,0.0001639274,0.002119373,0.004011148],"study_design_scores_gemma":[0.8992682,0.01041238,0.00003247051,0.0001269894,0.002525004,0.000003966682,0.001802608,0.08201703,0.001576986,0.0002648804,0.001609377,0.0003601241],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.04721722,0.0001056023,0.005384861,0.0013899,0.0004819813,0.944834,0.0001851326,0.0001575364,0.0002437977],"genre_scores_gemma":[0.01513143,0.000008321504,0.04236481,0.0005518997,0.00189218,0.9385043,0.0002037373,0.0001051541,0.001238115],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.1152139,"threshold_uncertainty_score":0.9998486,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3160762487777927,"score_gpt":0.5386381678082232,"score_spread":0.2225619190304305,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}